BioTime, Inc. (NYSE: BTX) today announced that detailed data from the successful pivotal trial of Renevia® in Europe was presented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE